Ethosuximide

CAS No. 77-67-8

Ethosuximide( CI-366 | NSC 64013 )

Catalog No. M15932 CAS No. 77-67-8

An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 54 In Stock
100MG Get Quote In Stock
200MG 33 In Stock
500MG 49 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ethosuximide
  • Note
    Research use only, not for human use.
  • Brief Description
    An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
  • Description
    An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CI-366 | NSC 64013
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    77-67-8
  • Formula Weight
    141.17
  • Molecular Formula
    C7H11NO2
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 39.2 g/L
  • SMILES
    O=C(C(C)(CC)C1)NC1=O
  • Chemical Name
    3-Ethyl-3-methyl-2,5-pyrrolidinedione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gomora JC, et al. Mol Pharmacol. 2001 Nov; 60(5):1121-32.
molnova catalog
related products
  • Upacicalcet

    Upacicalcet (AJT-240) is an intraventricular calcium mimetic, a SHPT available for human hemodialysis, that inhibits excessive parathyroid hormone (PTH) secretion by directly acting on parathyroid cell membrane calcium-sensitive receptors, thereby lowering blood levels of PTH.

  • Lomerizine hydrochlo...

    Lomerizine dihydrochloride is a relatively new L- and T-type calcium channel blocker used in the treatment of migraine.

  • JTV-519 fumarate

    JTV-519 (K201) is a Ca2+-dependent blocker of SERCA and a partial agonist of ryanodine receptors (RyRs).